Organogenesis (NASDAQ:ORGO) Announces Earnings Results, Beats Estimates By $0.11 EPS

Organogenesis (NASDAQ:ORGO) released its earnings results on Tuesday. The company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.11, Zacks reports. Organogenesis had a negative net margin of 1.62% and a negative return on equity of 2.69%. The business had revenue of $115.18 million for the quarter, compared to analyst estimates of $109.59 million. During the same quarter in the previous year, the business earned $0.02 earnings per share. Organogenesis updated its FY 2024 guidance to EPS.

Organogenesis Stock Down 5.0 %

Shares of Organogenesis stock traded down $0.20 on Friday, hitting $3.81. 147,065 shares of the company’s stock traded hands, compared to its average volume of 822,741. The company has a fifty day moving average of $2.97 and a two-hundred day moving average of $2.81. Organogenesis has a one year low of $2.16 and a one year high of $4.70. The company has a quick ratio of 2.42, a current ratio of 3.09 and a debt-to-equity ratio of 0.21.

Organogenesis Company Profile

Organogenesis Holdings Inc, a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane in which viable cells, growth factors/cytokines, and ECM proteins in the native tissue are preserved; Novachor, a chorion membrane in which viable cells, growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, cytokines, and growth factors; NuShield, dehydrated placental tissue covering amnion and chorion membranes for spongy/intermediate layer intact; and PuraPly AM, an antimicrobial barrier that enables conformability and fluid drainage.